XT Biomed will make its exhibition debut at the Med-Tech Innovation Expo 2025, taking place on 4–5 June at the NEC Birmingham. The company will exhibit at Stand B48 and showcase its comprehensive capabilities in the design, development, and manufacturing of medical devices, in-vitro diagnostics, and laboratory instruments.
With a proven track record supporting clients across the diagnostics, life sciences, and healthcare sectors, XT Biomed delivers integrated services covering everything from system architecture and mechanical engineering to electronics, software, rapid prototyping, production, servicing, and global distribution. Certified to ISO 13485, XT Biomed operates to the highest standards for quality and regulatory compliance, giving clients confidence throughout the entire product lifecycle.
Tom Cole, Managing Director of XT Biomed, shared his enthusiasm about the company’s exhibition debut. “Exhibiting at Med-Tech Innovation Expo is a significant milestone for us and reflects the momentum we’ve built over the past few years. We look forward to connecting with the medtech community, showcasing our full-service capabilities, and exploring how we can support more companies in bringing advanced medical technologies to market.”
XT Biomed partners with start-ups, scale-ups, and established OEMs, taking a collaborative approach to support clients at every stage of the product journey. Whether supporting the development of a new point-of-care diagnostic device or scaling up manufacturing for global markets, XT Biomed is committed to innovation, precision, and partnership.
Visit Stand B48 at the Med-Tech Innovation Expo to meet the XT team, view recent project successes, and explore how their end-to-end, ISO 13485-certified approach helps clients streamline medical device development, reduce risk, and accelerate time to market.
Learn more about innovative medical device design and manufacturing here.
